Showing results (61-70 of 156) with videos related to

Sort By:
Pageof 16
Leukemia Research|April 28, 2004
Angiogenesis in acute and chronic lymphocytic leukemiaStefano Molica, Angelo Vacca, Domenico Levato, et al.
Leukemia & Lymphoma|December 6, 2018
The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysisStefano Molica, Diana Giannarelli, Rosanna Mirabelli, et al.
Cancers|January 11, 2024
Venetoclax: A Game Changer in the Treatment of Younger AML Patients?Matteo Molica, Salvatore Perrone, Vincenzo Federico, et al.
Leukemia & Lymphoma|February 17, 2012
Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implicationsStefano Molica, Francesca Romana Mauro, Matteo Molica, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysisStefano Molica, Diana Giannarelli, Luciano Levato, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2008
Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision makingFabio Efficace, Georg Kemmler, Marco Vignetti, et al.
Cancer Management and Research|July 28, 2011
Clinical relevance and treatment of nonautoimmune anemia in chronic lymphocytic leukemiaStefano Molica, Rosanna Mirabelli, Matteo Molica, et al.
International Journal of Hematology|July 28, 2014
A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL)Stefano Molica, Diana Giannarelli, Luciano Levato, et al.
Chemotherapy|June 23, 2020
Sustained Complete Remission with Incomplete Hematologic Recovery (CRi) in a Patient with Relapsed AML and Concurrent BCR-ABL1 and CBFB Rearrangement Treated with a Combination of Venetoclax and 5-AzacytidineLuciano Levato, Valentina Gianfelici, Francesca Caglioti, et al.
Expert Review of Hematology|September 2, 2014
Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelinesStefano Molica, Diana Giannarelli, Rosanna Mirabelli, et al.
Pageof 16